Intelligence Hub
Market analytics and operational performance indicators
3 - April 6, 2026
Marvin Clevenger reported initial beneficial ownership as President of Rocket Lab USA Inc.
Brief
This SEC Form 3 filing discloses the initial statement of beneficial ownership for Marvin Bradford Clevenger. Mr. Clevenger has assumed the role of President, Rocket Lab USA Inc., effective March 26, 2026. The filing is a regulatory requirement for new officers to declare their holdings in the company.
Detailed Brief
The filing provides details on the equity holdings of Marvin Bradford Clevenger following his appointment as President of Rocket Lab USA Inc. The event requiring the statement occurred on March 26, 2026. This disclosure is standard procedure for new executive officers to ensure transparency regarding their stake in the issuer.
Mr. Clevenger holds a total of 492,435 shares of Common Stock. This total includes 282,679 restricted stock units (RSUs) granted under the Rocket Lab Corporation 2021 Stock Option and Incentive Plan, which represent a contingent right to receive one share of common stock per unit. The remaining shares are held directly.
Key Telemetry
- • Marvin Bradford Clevenger appointed as President, Rocket Lab USA Inc.
- • Total common stock beneficially owned: 492,435 shares.
- • Includes 282,679 restricted stock units (RSUs) under the 2021 Stock Option and Incentive Plan.
- • Effective date of reporting event: March 26, 2026.
Impact Vector
This is a routine regulatory filing associated with an executive leadership transition. For investors, the appointment of a President and the disclosure of their equity stake provides clarity on leadership and alignment of interests. There are no immediate material implications for the company's capital structure or operations disclosed in this filing; investors should monitor future Form 4 filings to track subsequent trading activity by this executive.